A D-Xylopyranosyl-phenyl-substituted cycle compound of general formula I
wherein the groups R.sup.1 to R.sup.6, Z, X, Cy and R.sup.7a, R.sup.7b
and R.sup.7c are defined as in claim 1, have an inhibiting effect on the
sodium-dependent glucose cotransporter SGLT. The present invention also
relates to pharmaceutical compositions for the treatment of metabolic
disorders.